drugset / Trial / NCT02160132

A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.

NCT02160132 ↗

Phase 2 Unknown 180 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective, randomized, controlled, multi-center clinical trial will evaluate the effect and security of steroids therapy for patients of IgA nephropathy with active pathological changes,including crescents,necrosis and microthrombus.

Timeline

Start
2014-06
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 0.4 mg/kg Intravenous